Imiquimod

5 trials 1 recruiting DDermatology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

3 Completed trials

5 Sponsors

6 Countries

Phase III

Phase II

Phase I/II

Phase III: 1 Phase II: 2 Phase I/II: 2

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Actinic keratosis 1 Hepatic cirrhosis 1

Sponsors using this IMP

AiCuris Anti-infective Cures AG 1 Centre Leon Berard 1 CHRU De Nancy 1 Instituto Oncologico Dr. Rosell S.L. 1 Laboratorios Normon S.A. 1

All trials

5 total

COLOMBE - A multicentre, single arm, phase 1/2 study, aiming to assess the safety and efficacy of nivolumab and imiquimod combination in vul… Pending

2025-524759-29-00 Phase I/II 1 country Centre Leon Berard
Neoadjuvant Cemiplimab Plus Imiquimod in Cutaneous Basal Cell Carcinoma. Recruiting

2025-520698-38-00 Phase I/II 1 country Instituto Oncologico Dr. Rosell S.L.
An exploratory, multicenter, randomized, open-label with blind evaluation, active controlled study to evaluate the safety and efficacy of Ke… Ended

2024-515667-60-00 Phase II 1 country Laboratorios Ojer Pharma S.L.
Effectiveness and Safety of Intra-Dermal Hepatitis B Vaccination after a local application of cream, called IMIQUIMOD, in cirrhotic patients… Ended

2024-514605-61-00 Phase II 1 country CHRU De Nancy
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections … Ended

2023-510088-37-00 Phase III 5 countries AiCuris Anti-infective Cures AG

Showing 1–5 of 5 trials

← All drugs A–Z